Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp acquired a new position in shares of HealthSouth Corp. (NYSE:HLS) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 38,030 shares of the company’s stock, valued at approximately $1,543,000.

Several other institutional investors have also recently added to or reduced their stakes in the stock. American Century Companies Inc. purchased a new position in HealthSouth Corp. during the second quarter worth approximately $6,174,000. Moody Aldrich Partners LLC raised its stake in shares of HealthSouth Corp. by 2.9% in the second quarter. Moody Aldrich Partners LLC now owns 15,065 shares of the company’s stock valued at $585,000 after buying an additional 420 shares during the last quarter. Cumberland Partners Ltd raised its stake in shares of HealthSouth Corp. by 178.5% in the second quarter. Cumberland Partners Ltd now owns 559,025 shares of the company’s stock valued at $21,702,000 after buying an additional 358,325 shares during the last quarter. Genesee Valley Trust Co. raised its stake in shares of HealthSouth Corp. by 5.2% in the second quarter. Genesee Valley Trust Co. now owns 8,142 shares of the company’s stock valued at $316,000 after buying an additional 402 shares during the last quarter. Finally, Bank of Montreal Can bought a new stake in shares of HealthSouth Corp. during the second quarter valued at about $22,389,000. Institutional investors own 97.23% of the company’s stock.

Institutional Ownership by Quarter for HealthSouth Corp. (NYSE:HLS)

HealthSouth Corp. (NYSE:HLS) traded down 0.81% on Wednesday, hitting $41.67. 1,568,717 shares of the company’s stock traded hands. The stock has a 50 day moving average price of $40.24 and a 200-day moving average price of $40.45. The stock has a market cap of $3.74 billion, a P/E ratio of 17.37 and a beta of 0.90. HealthSouth Corp. has a 12 month low of $30.26 and a 12 month high of $43.38.

HealthSouth Corp. (NYSE:HLS) last released its earnings results on Thursday, October 27th. The company reported $0.65 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.60 by $0.05. The company earned $926.80 million during the quarter, compared to analyst estimates of $448.60 million. HealthSouth Corp. had a net margin of 6.31% and a return on equity of 29.27%. The firm’s quarterly revenue was up 19.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.52 EPS. Equities analysts predict that HealthSouth Corp. will post $2.55 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, January 17th. Investors of record on Tuesday, January 3rd will be issued a $0.24 dividend. This represents a $0.96 annualized dividend and a yield of 2.30%. The ex-dividend date of this dividend is Thursday, December 29th. HealthSouth Corp.’s dividend payout ratio is 40.17%.

TRADEMARK VIOLATION WARNING: “Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp Acquires Shares of 38,030 HealthSouth Corp. (HLS)” was first reported by Daily Political and is owned by of Daily Political. If you are accessing this piece on another site, it was copied illegally and republished in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at http://www.dailypolitical.com/2016/11/30/her-majesty-the-queen-in-right-of-the-province-of-alberta-as-represented-by-alberta-investment-management-corp-acquires-shares-of-38030-healthsouth-corp-hls.html.

HLS has been the subject of several research analyst reports. Zacks Investment Research upgraded shares of HealthSouth Corp. from a “hold” rating to a “buy” rating and set a $45.00 target price for the company in a research report on Monday, October 31st. Wells Fargo & Co. reiterated a “buy” rating on shares of HealthSouth Corp. in a research report on Sunday, September 11th. JMP Securities reiterated a “buy” rating on shares of HealthSouth Corp. in a research report on Sunday, September 4th. Mizuho lowered shares of HealthSouth Corp. from a “buy” rating to a “neutral” rating in a research report on Wednesday, November 9th. Finally, RBC Capital Markets reiterated an “outperform” rating and set a $48.00 target price (up from $46.00) on shares of HealthSouth Corp. in a research report on Monday, October 31st. One research analyst has rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $46.57.

In other HealthSouth Corp. news, COO Mark J. Tarr purchased 6,371 shares of the company’s stock in a transaction on Wednesday, November 9th. The stock was acquired at an average cost of $39.29 per share, for a total transaction of $250,316.59. Following the purchase, the chief operating officer now directly owns 238,890 shares of the company’s stock, valued at approximately $9,385,988.10. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Douglas E. Coltharp purchased 6,450 shares of the company’s stock in a transaction on Wednesday, November 9th. The stock was acquired at an average price of $39.14 per share, with a total value of $252,453.00. Following the completion of the purchase, the chief financial officer now directly owns 104,637 shares in the company, valued at $4,095,492.18. The disclosure for this purchase can be found here. 5.00% of the stock is currently owned by corporate insiders.

About HealthSouth Corp.

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in over 30 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company’s segments include inpatient rehabilitation, and home health and hospice.

5 Day Chart for NYSE:HLS

Want to see what other hedge funds are holding HLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthSouth Corp. (NYSE:HLS).

Receive News & Ratings for HealthSouth Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corp. and related companies with MarketBeat.com's FREE daily email newsletter.